Clearline Capital LP - 30 Sep 2025 SCHEDULE 13G Report for HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX)

Filing Manager
Clearline Capital LP
Reporting Manager
Clearline Capital LP
Security
HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share
Symbol
HRTX
Shares outstanding
183,255,226 shares
Disclosed Ownership
9,712,527 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
26 Nov 2025, 10:15:35 UTC
Date of event
30 Sep 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Clearline Capital LP 5.3% 9,712,527 0 9,712,527 Marc Majzner Limited Partner
Clearline Capital LLC 5.3% 9,712,527 0 9,712,527 Marc Majzner Managing Member
Marc Majzner 5.3% 9,712,527 0 9,712,527 Marc Majzner Authorized Signatory